Log on / register
Feedback | Support | My details
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
DeHart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Argañaraz ER, Planelles V
Virol J 2007, 4:57
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.
Dehart JL, Planelles V
J Virol 2008 Feb, 82:1066-72
 [PubMed Central] [PubMed] [Related articles]
2.
Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction.
Kitayama H, Miura Y, Ando Y, Hoshino S, Ishizaka Y, Koyanagi Y
J Virol 2008 Mar, 82:2528-42
 [PubMed Central] [PubMed] [Related articles]
3.
Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction.
Sharova N, Wu Y, Zhu X, Stranska R, Kaushik R, Sharkey M, Stevenson M
PLoS Pathog 2008 May, 4:e1000057
 [PubMed Central] [PubMed] [Related articles]
4.
Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection.
Srivastava S, Swanson SK, Manel N, Florens L, Washburn MP, Skowronski J
PLoS Pathog 2008 May, 4:e1000059
 [PubMed Central] [PubMed] [Related articles]
5.
Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.
DeHart JL, Bosque A, Harris RS, Planelles V
J Virol 2008 Sep, 82:9265-72
 [PubMed Central] [PubMed] [Related articles]
6.
Human immunodeficiency virus type 1 Vpr-binding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential for DNA replication and embryonic development.
McCall CM, Miliani de Marval PL, Chastain PD, Jackson SC, He YJ, Kotake Y, Cook JG, Xiong Y
Mol Cell Biol 2008 Sep, 28:5621-33
 [PubMed Central] [PubMed] [Related articles]
7.
Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.
Goujon C, Arfi V, Pertel T, Luban J, Lienard J, Rigal D, Darlix JL, Cimarelli A
J Virol 2008 Dec, 82:12335-45
 [PubMed Central] [PubMed] [Related articles]
8.
HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.
Andersen JL, Le Rouzic E, Planelles V
Exp Mol Pathol 2008 Aug, 85:2-10
 [PubMed Central] [PubMed] [Related articles]
9.
The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.
Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C
J Virol 2009 May, 83:4854-60
 [PubMed Central] [PubMed] [Related articles]
10.
HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E
PLoS Pathog 2009 Oct, 5:e1000613
 [PubMed Central] [PubMed] [Related articles]
11.
Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.
Jacquot G, Le Rouzic E, Maidou-Peindara P, Maizy M, Lefrère JJ, Daneluzzi V, Monteiro-Filho CM, Hong D, Planelles V, Morand-Joubert L, Benichou S
PLoS One 2009, 4:e7514
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.